Show simple item record

dc.contributor.authorTang, Sammer
dc.contributor.authorBrady, Mike
dc.contributor.authorMildenhall, Joanne
dc.contributor.authorRolfe, Ursula
dc.contributor.authorBowles, Alexandra
dc.contributor.authorMorgan, Kirsty
dc.date.accessioned2020-07-24T11:27:54Z
dc.date.available2020-07-24T11:27:54Z
dc.date.issued2020-05-05
dc.identifier.citationTang, S. et al, 2020. The new coronavirus disease: what do we know so far? Journal of Paramedic Practice, 12 (5), 193-201.en_US
dc.identifier.issn1759-1376
dc.identifier.issn2041-9457
dc.identifier.doi10.12968/jpar.2020.12.5.193
dc.identifier.urihttp://hdl.handle.net/20.500.12417/840
dc.description.abstractView Article Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that causes the new disease COVID-19. Symptoms range from mild to severe with a higher incidence of severe cases in patients with risk factors such as older age and comorbidities. COVID-19 is mainly spread through the inhalation of respiratory droplets from coughing or sneezing or via contact with droplet-contaminated surfaces. Paramedics should be aware that some aerosol-generating procedures may put them at a higher risk of contracting the virus via possible airborne transmission. Use of remote triage clinical assessment is likely to increase as a result of the pandemic. There is no curative drug treatment for the virus and some medications may exacerbate its effects or make patients more susceptible to it. Evidence and guidelines are evolving on SARS-CoV-2 and COVID-19. Paramedics should keep up to date with the latest clinical guidance from their employers. Abstract published with permission.
dc.language.isoenen_US
dc.subjectEmergency Medical Servicesen_US
dc.subjectCOVID-19en_US
dc.subjectPandemicsen_US
dc.subjectCoronavirusen_US
dc.subjectInfection Controlen_US
dc.titleThe new coronavirus disease: what do we know so far?en_US
dc.typeJournal Article/Review
dc.source.journaltitleJournal of Paramedic Practiceen_US
dcterms.dateAccepted2020-07-09
rioxxterms.versionNAen_US
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden_US
rioxxterms.licenseref.startdate2020-07-09
refterms.panelUnspecifieden_US
refterms.dateFirstOnline2020-05-05
html.description.abstractView Article Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that causes the new disease COVID-19. Symptoms range from mild to severe with a higher incidence of severe cases in patients with risk factors such as older age and comorbidities. COVID-19 is mainly spread through the inhalation of respiratory droplets from coughing or sneezing or via contact with droplet-contaminated surfaces. Paramedics should be aware that some aerosol-generating procedures may put them at a higher risk of contracting the virus via possible airborne transmission. Use of remote triage clinical assessment is likely to increase as a result of the pandemic. There is no curative drug treatment for the virus and some medications may exacerbate its effects or make patients more susceptible to it. Evidence and guidelines are evolving on SARS-CoV-2 and COVID-19. Paramedics should keep up to date with the latest clinical guidance from their employers. Abstract published with permission.en_US


This item appears in the following Collection(s)

Show simple item record